Search reports.
Aptamers Market Size, Share, Growth & Industry Trends 2031
Get free sample report Request for Customiztion Buy Now

Aptamers Market Size, Share, Growth & Industry Trends 2031

Segments - Aptamers Market by Types (Nucleic Acid and Peptide), Applications (Diagnostics, Therapeutics, Research and Development, and Others), and Regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-774 | 4.1 Rating | 73 Reviews | 184 Pages | Format : PDF Excel PPT

Report Description


Aptamers Market Outlook 2031

The global aptamers market size was USD 177.73 Billion in 2022 and is anticipated to reach USD 770.46 Billion by 2031 expand at a robust CAGR 17.7% during the forecast period, 2023-2031. The growth of the market is attributed to numerous advantages offered by these small molecules in comparison to established antibodies.

Aptamer is an artificial chemical antibody that is generated from the randomized nucleic acid library by three simple steps, which are binding, separation, and amplification. The selected aptamer has a high binding affinity with the target molecule. In most cases, aptamer was found to be better than other antibodies.

Aptamers Market Outlook

Aptamers are short, single-stranded DNA or RNA molecules that can selectively bind to a specific target, including proteins, peptides, carbohydrates, small molecules, toxins, and even live cells. These molecules have a variety of shapes due to their tendency to form helices and single-stranded loops. The huge number of possible tertiary structures allow aptamers to bind with high affinity through van der Waals, hydrogen bonding, and electrostatic interactions, to peptides or protein targets.

  • Ongoing advancement in aptamer development technologies is a prominent driver that is expected to contribute to the growth of the global aptamers market.
  • Increasing research and development expenditure is augment the aptamers market growth.
  • Lack of awareness of these technologies in middle and low-income countries can act as major restraints of the market.
  • Many aptamers have failed to meet the requisite safety and clinical studies. Thus, companies had to terminate their clinical investigation, which in turn, can hamper the market growth.
  • The outbreak of COVID-19 had negatively impacted the aptamers market. However, the market is anticipated to recover soon.
  • Aptamers are chemically synthesized, which eliminates batch-to-batch variation and demands less time for development. This factor can create lucrative opportunities for industry players during the forecast period.

Scope of The Aptamers Market Report

The report on the global aptamers market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Aptamers Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Types (Nucleic Acid and Peptide) and Applications (Diagnostics, Therapeutics, Research and Development, and Others)

Regional scope

North America, Latin America, Europe, Asia Pacific and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Aptagen, LLC., Base Pair Biotechnologies, Inc., NOXXON Pharma, SomaLogic Inc., and Aptamer Group, AM Biotechnologies LLC, Aptamer Sciences Inc., Aptus Biotech S.L., TriLink BioTechnologies Inc., and Vivonics Inc.

Aptamers Market Segment Insights:

Nucleic acid segment to grow at a rapid pace

Based on types, the market is divided into nucleic acid and peptide. The nucleic acid segment is anticipated to account for a key share and is anticipated to grow at a steady rate during the forecast period. Rising research and development initiatives on DNA-based aptamers is driving the segment growth. Nucleic acid-based aptamers are chemically equivalent of antibodies and can form secondary and tertiary structures that are capable of specifically binding proteins or other cellular targets, contributing to the segment growth.

Aptamers Market Types

Diagnostics segment to account a major market share

Based on applications, the market is divided into diagnostics, therapeutics, research and development, and others. The diagnostics segment is anticipated to account for a major share due to rising demand of aptamers. These molecules are presently being used as a bio-recognition element in a variety of diagnostic systems in order to detect viral proteins, either in the blood or infected cells.

Aptamers Market applications

North America to account a considerable market share

On the basis of regions, the market is segregated into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. The market in North America is anticipated to dominate the aptamers market due to rapid technological advancements and high investment and funding to support the development of aptamers. Moreover, growing acceptance of personalized medicine is aiding the market grow in the region.

Aptamers Market Regions                 

Segments


The global aptamers has been segmented on the basis of

Types

  • Nucleic Acid
  • Peptide

Applications

  • Diagnostics
  • Therapeutics
  • Research and Development
  • Others

Key Players

Competitive Landscape

The major players of the market are Aptagen, LLC., Base Pair Biotechnologies, Inc., NOXXON Pharma, SomaLogic Inc., Aptamer Group, AM Biotechnologies LLC, Aptamer Sciences Inc., Aptus Biotech S.L., TriLink BioTechnologies Inc., and Vivonics Inc.

Companies are focusing on innovation, expansion, and acquisitions to expand their market share.

Aptamers Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Aptamers Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Aptamers Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Aptamers Market - Supply Chain
  4.5. Global Aptamers Market Forecast
     4.5.1. Aptamers Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Aptamers Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Aptamers Market Absolute $ Opportunity
5. Global Aptamers Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Aptamers Market Size and Volume Forecast by Types
     5.3.1. Nucleic Acid
     5.3.2. Peptide
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Aptamers Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Aptamers Market Size and Volume Forecast by Applications
     6.3.1. Diagnostics
     6.3.2. Therapeutics
     6.3.3. Research and Development
     6.3.4. Others
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Aptamers Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Aptamers Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Aptamers Demand Share Forecast, 2019-2026
8. North America Aptamers Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Aptamers Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Aptamers Market Size and Volume Forecast by Types
     8.4.1. Nucleic Acid
     8.4.2. Peptide
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Aptamers Market Size and Volume Forecast by Applications
     8.7.1. Diagnostics
     8.7.2. Therapeutics
     8.7.3. Research and Development
     8.7.4. Others
  8.8. Basis Point Share (BPS) Analysis by Applications
  8.9. Y-o-Y Growth Projections by Applications
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Aptamers Demand Share Forecast, 2019-2026
9. Latin America Aptamers Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Aptamers Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Aptamers Market Size and Volume Forecast by Types
     9.4.1. Nucleic Acid
     9.4.2. Peptide
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Aptamers Market Size and Volume Forecast by Applications
     9.7.1. Diagnostics
     9.7.2. Therapeutics
     9.7.3. Research and Development
     9.7.4. Others
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Aptamers Demand Share Forecast, 2019-2026
10. Europe Aptamers Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Aptamers Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Aptamers Market Size and Volume Forecast by Types
     10.4.1. Nucleic Acid
     10.4.2. Peptide
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Aptamers Market Size and Volume Forecast by Applications
     10.7.1. Diagnostics
     10.7.2. Therapeutics
     10.7.3. Research and Development
     10.7.4. Others
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Aptamers Demand Share Forecast, 2019-2026
11. Asia Pacific Aptamers Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Aptamers Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Aptamers Market Size and Volume Forecast by Types
     11.4.1. Nucleic Acid
     11.4.2. Peptide
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Aptamers Market Size and Volume Forecast by Applications
     11.7.1. Diagnostics
     11.7.2. Therapeutics
     11.7.3. Research and Development
     11.7.4. Others
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Aptamers Demand Share Forecast, 2019-2026
12. Middle East & Africa Aptamers Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Aptamers Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Aptamers Market Size and Volume Forecast by Types
     12.4.1. Nucleic Acid
     12.4.2. Peptide
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Aptamers Market Size and Volume Forecast by Applications
     12.7.1. Diagnostics
     12.7.2. Therapeutics
     12.7.3. Research and Development
     12.7.4. Others
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Aptamers Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Aptamers Market: Market Share Analysis
  13.2. Aptamers Distributors and Customers
  13.3. Aptamers Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Aptagen, LLC
     13.4.2. Base Pair Biotechnologies, Inc.
     13.4.3. NOXXON Pharma
     13.4.4. SomaLogic Inc.
     13.4.5. Aptamer Group
     13.4.6. AM Biotechnologies LLC
     13.4.7. Aptamer Sciences Inc.
     13.4.8. Aptus Biotech S.L.
     13.4.9. TriLink BioTechnologies Inc.
     13.4.10. Vivonics Inc

Methodology

Our Clients

Microsoft
Dassault Aviation
Pfizer
Siemens Healthcare
Deloitte
FedEx Logistics
Honda Motor Co. Ltd.
sinopec